Metabolomics and microbial composition increase insight into the impact of dietary differences in cirrhosis.
Mediterranean diet
Western diet
cirrhosis
fermented milk products
gut microbial function
metabolomics
Journal
Liver international : official journal of the International Association for the Study of the Liver
ISSN: 1478-3231
Titre abrégé: Liver Int
Pays: United States
ID NLM: 101160857
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
09
07
2019
revised:
04
09
2019
accepted:
17
09
2019
pubmed:
24
9
2019
medline:
22
6
2021
entrez:
24
9
2019
Statut:
ppublish
Résumé
Dietary changes can modulate gut microbiota and interact with cirrhosis. Our prior study demonstrated that microbial diversity was higher in cirrhotics from Turkish vs the USA, which was associated with lower risk of 90-day hospitalizations. We aimed to define gut microbial functional and metabolomic changes to increase insight into benefits of the Mediterranean compared to Western diets. In all, 139 Turkish (46 controls/50 compensated/43 decompensated) and 157 American subjects (48 controls/59 compensated/50 decompensated) were studied. Turkish subjects consumed a modified Mediterranean diet with daily fermented milk intake, whereas Americans consumed a Western diet. Predicted gut microbial functionalities and plasma metabolomics were compared between/within countries. Correlation network differences between microbiota and metabolites in cirrhotics from Turkey vs the USA were evaluated. Predicted microbial function showed lower amino acid, bioenergetics and lipid pathways, with functions related to vitamin B, glycan, xenobiotic metabolism, DNA/RNA synthesis, in cirrhotics from Turkey compared to the USA. Plasma metabolomics demonstrated higher relative lactate levels in Turkey vs the USA. The metabolite changes in decompensated cirrhosis, compared to controls, showed similar trends in Turkey and the USA, with reduced lipids and phosphocholines. Phosphocholines were significantly lower in patients hospitalized in 90 days (P = .03). Correlation networks in cirrhotics demonstrated linkage differences between beneficial taxa, Blautia and Oscillispira, and lactate and unsaturated lipids, in Turkey compared to American patients. A modified Mediterranean diet was associated with altered plasma metabolomics and beneficially alters microbiota functionality and correlations compared to Western diet in cirrhosis. These altered diet-microbial interactions could potentially affect the 90-day hospitalization risk.
Sections du résumé
BACKGROUND & AIMS
Dietary changes can modulate gut microbiota and interact with cirrhosis. Our prior study demonstrated that microbial diversity was higher in cirrhotics from Turkish vs the USA, which was associated with lower risk of 90-day hospitalizations. We aimed to define gut microbial functional and metabolomic changes to increase insight into benefits of the Mediterranean compared to Western diets.
METHODS
In all, 139 Turkish (46 controls/50 compensated/43 decompensated) and 157 American subjects (48 controls/59 compensated/50 decompensated) were studied. Turkish subjects consumed a modified Mediterranean diet with daily fermented milk intake, whereas Americans consumed a Western diet. Predicted gut microbial functionalities and plasma metabolomics were compared between/within countries. Correlation network differences between microbiota and metabolites in cirrhotics from Turkey vs the USA were evaluated.
RESULTS
Predicted microbial function showed lower amino acid, bioenergetics and lipid pathways, with functions related to vitamin B, glycan, xenobiotic metabolism, DNA/RNA synthesis, in cirrhotics from Turkey compared to the USA. Plasma metabolomics demonstrated higher relative lactate levels in Turkey vs the USA. The metabolite changes in decompensated cirrhosis, compared to controls, showed similar trends in Turkey and the USA, with reduced lipids and phosphocholines. Phosphocholines were significantly lower in patients hospitalized in 90 days (P = .03). Correlation networks in cirrhotics demonstrated linkage differences between beneficial taxa, Blautia and Oscillispira, and lactate and unsaturated lipids, in Turkey compared to American patients.
CONCLUSIONS
A modified Mediterranean diet was associated with altered plasma metabolomics and beneficially alters microbiota functionality and correlations compared to Western diet in cirrhosis. These altered diet-microbial interactions could potentially affect the 90-day hospitalization risk.
Identifiants
pubmed: 31544308
doi: 10.1111/liv.14256
pmc: PMC6980909
mid: NIHMS1051590
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
416-427Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : CSRD VA
ID : I01 CX001076
Pays : United States
Organisme : NCATS NIH HHS
ID : R21 TR002024
Pays : United States
Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Lancet. 2008 Mar 8;371(9615):838-51
pubmed: 18328931
Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):35-56
pubmed: 30262901
Liver Int. 2018 Jan;38(1):50-58
pubmed: 28561276
Cell Metab. 2006 May;3(5):321-31
pubmed: 16679290
Nat Commun. 2018 Sep 14;9(1):3760
pubmed: 30218046
Am J Gastroenterol. 2018 Aug;113(8):1177-1186
pubmed: 29872220
J Hepatol. 2016 May;64(5):1058-1067
pubmed: 26795831
Front Microbiol. 2016 Feb 17;7:185
pubmed: 26925050
Nucleic Acids Res. 2018 Jul 2;46(W1):W486-W494
pubmed: 29762782
Hepatology. 2011 Aug;54(2):562-72
pubmed: 21574172
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Nucleic Acids Res. 2013 Jan;41(Database issue):D801-7
pubmed: 23161693
Nat Biotechnol. 2013 Sep;31(9):814-21
pubmed: 23975157
Z Ernahrungswiss. 1991 Jun;30(2):131-7
pubmed: 1897274
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2117-22
pubmed: 18252821
J Hepatol. 2013 May;58(5):949-55
pubmed: 23333527
Elife. 2013 Nov 05;2:e01202
pubmed: 24192039
Clin Gastroenterol Hepatol. 2019 Jan;17(2):218-230
pubmed: 30240894
Chem Biodivers. 2010 May;7(5):1065-75
pubmed: 20491064
Nature. 2015 Dec 10;528(7581):262-266
pubmed: 26633628
Am J Physiol Regul Integr Comp Physiol. 2009 Jul;297(1):R202-9
pubmed: 19458279
Nutrients. 2010 Nov;2(11):1141-55
pubmed: 22254002
Liver Int. 2015 Feb;35(2):362-9
pubmed: 24836902
Science. 2011 Oct 7;334(6052):105-8
pubmed: 21885731
Hepatology. 2018 Jul;68(1):234-247
pubmed: 29350768
Dis Markers. 2011;31(3):121-8
pubmed: 22045397
Genome Biol. 2012 Apr 16;13(9):R79
pubmed: 23013615
Gut. 1978 Jun;19(6):526-30
pubmed: 355066
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):539-42
pubmed: 25846450
Hepatology. 1995 Feb;21(2):417-27
pubmed: 7843715
Microbiome. 2018 Aug 2;6(1):133
pubmed: 30071894
Nature. 2018 Mar 8;555(7695):210-215
pubmed: 29489753